Noveome Biotherapeutics

Noveome to assess ST266 to treat severe inflammatory response linked with COVID-19
Pharmaceutical Business Review
Tue, 03/31/20 - 11:08 am
Noveome Biotherapeutics
ST266
cytokine storm
COVID-19
Noveome Biotherapeutics initiates trial evaluating intranasal delivery of ST266 targeting optic nerve and brain
Pharmaceutical Business Review
Fri, 09/27/19 - 10:44 am
Noveome Biotherapeutics
clinical tirals
ST266
intraocular hypertension